Society ❯ Healthcare Access

Patient Advocacy

Drug Affordability Public Health Insurance Issues Insurance Coverage Screening Programs Drug Pricing Issues Charities Drug Costs Insurance Transparency Senior Citizens Cost Burden Drug Pricing Pharmacy Compounding Cost Reduction Consumer Rights Drug Affordability Issues Hospital Regulations Mental Health Services Health Disparities Charitable Organizations Financial Aid Healthcare Quality End-of-Life Care Patient Information Cost of Medications Medical Costs Industry Standards Family Support Health Complaints Cannabis Associations Pharmacy Services Insurance Regulation Affordability Cost of Medicines Family Involvement Insurance Challenges Affordable Healthcare Medicare Beneficiaries Drug Innovation Medical Treatment Medical Innovation Medical Professionals Community Health Rights and Responsibilities Legislative Impact Alzheimer's Society

AstraZeneca Strikes White House Drug-Price Deal, Wins Three-Year Tariff Reprieve

Months of quiet outreach culminating in a fast-tracked Virginia plant deal helped the drugmaker secure terms tied to the TrumpRx plan.

Bristol Myers Sets U.K. Price for New Schizophrenia Drug Equal to U.S., Threatens to Pull Product

Double-Blind Trial Confirms Shunt Surgery Improves Gait in Older Adults With Normal-Pressure Hydrocephalus

California Weighs PBM Limits in Senate Bill 41 as Pharmacists Split on Costs and Access

FDA Investigates Fatal Liver Failures Linked to Sarepta’s Elevidys Therapy

FDA Ends GLP-1 Drug Shortages, Triggering New Pricing and Coverage Moves